期刊
MOLECULAR ENDOCRINOLOGY
卷 19, 期 6, 页码 1618-1628出版社
OXFORD UNIV PRESS INC
DOI: 10.1210/me.2004-0503
关键词
-
资金
- NHLBI NIH HHS [R01 HL066399] Funding Source: Medline
Alterations in TR [thyroid hormone (TH) receptor] 1 isoform expression have been reported in models of both physiologic and pathologic cardiac hypertrophy as well as in patients with heart failure. In this report, we demonstrate that TH induces hypertrophy as a direct result of binding to the TR alpha(1) isoform and, moreover, that overexpression of TR alpha(1) alone is also associated with a hypertrophic phenotype, even in the absence of ligand. The mechanism of TH and TR alpha(1)-specific hypertrophy is novel for a nuclear hormone receptor and involves the transforming growth factor beta-activated kinase (TAK1) and p38. Mitigating TR alpha(1) effects, both TR alpha(2) and TR beta(1) attenuate TR alpha(1)-induced myocardial growth and gene expression by diminishing TAK1 and p38 activities, respectively. These findings refine our previous observations on TR expression in the hypertrophied and failing heart and suggest that manipulation of thyroid hormone signaling in an isoform-specific manner may be a relevant therapeutic target for altering the pathologic myocardial program.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据